Contemporary Medical Therapies for Patients with Peripheral Artery Disease and Concomitant Type 2 Diabetes Mellitus: a Review of Current Evidence

Narcisse, Dennis; Katzenberger, D R; Gutiérrez, Jorge

doi:10.1007/s11886-022-01677-6

Cited by 2 publications

(1 citation statement)

References 71 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Guideline‐recommended treatment is often not performed. Although a major amount of knowledge, therapies, caretaking concepts, and patient education programs exist 70 , 71 and would help reduce the disease burden, the implementation is largely insufficient. Furthermore, a large number of patients from poorer countries does not have access to all therapy options including lack of continuous medical monitoring.…”

Section: Discussionmentioning

confidence: 99%

Temporal trends in patients with peripheral artery disease influenced by diabetes mellitus in Germany

Schmitt

Hobohm

Vosseler

et al. 2022

Journal of Diabetes

View full text Add to dashboard Cite

Introduction In patients with peripheral artery disease (PAD) the presence of diabetes mellitus (DM) is associated with higher morbidity and mortality. Because huge efforts are made to improve medical care of patients with DM including chronic disease programs, the aim of the present study was to investigate temporal trends regarding the clinical burden of DM on PAD patients within a 15‐year observational period. Methods We analyzed all patients hospitalized because of PAD between 2005 and 2019 in Germany stratified regarding DM. Results Overall, 2 654 871 hospitalizations of PAD patients (865 823 with DM) were included. Hospitalizations based on PAD inclined from 142 778 in 2005 to 190 135 in 2019 ( β 3956 per year; 95% confidence interval [CI] 3034–4878, p < .001) with simultaneous increase of hospitalizations of PAD patients with DM (2005: 41609 (29.1%) versus 2019: 65 302 (34.3%); β 2019 per year [95% CI 1593–2446], p < .001). Amputation rates ( β −0.42 [95% CI −0.44 to −0.40]; p < .001) as well as in‐hospital case‐fatality rate (2005: 4.7%, 2019: 2.8%; β −0.64 [95% CI −0.69 to −0.59]; p < .001) decreased in diabetic PAD patients during the observational time. In spite of improved morbidity and mortality in the last years of the observational period, patients with DM still suffered from an increased risk for morbidity and mortality during the observational period compared to nondiabetic PAD patients. Conclusions Despite the progress in DM treatments, DM still was associated with an unfavorable clinical patient profile and remained a substantial risk factor for morbidity and mortality in hospitalized patients with PAD and DM in Germany between 2005 and 2019.

show abstract

Section: Discussionmentioning

confidence: 99%